For its second fiscal quarter (ending June 30), AtriCure Inc (NASDAQ: ATRC) has reported E.P.S. of $-0.17 compared to $-0.11 a year ago. E.P.S. were $-0.86 for the latest four quarters through June 30 versus $-0.61 for the same period a year ago.
Recent Price Action
AtriCure Inc (NASDAQ: ATRC) stock rose slightly by 0.2% on 7/30/24. The stock closed at $22.00. Moreover, trading volume in this advance was unusually high at 168% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -7.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ATRC is expected to continue to be Value Creation neutral.
AtriCure has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. AtriCure has a poor Appreciation Score of 16 and a very low Power Rating of 2, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment